McCallister, Scott <br/><br/>
A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Apr 2004 
 - 376-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/00126334-200404010-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD4 Lymphocyte Count<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--administration & dosage<br/>HIV-1<br/>Humans<br/>Pyridines--administration & dosage<br/>Pyrones--administration & dosage<br/>RNA, Viral--blood<br/>Ritonavir--administration & dosage<br/>Sulfonamides